Elon Musk implants brain chip in first human at Neuralink
Neuralink Implants First Human Patient with Brain-Chip
(Reuters) – The first human patient has received an implant from brain-chip startup Neuralink on Sunday and is recovering well, according to Elon Musk, the company’s billionaire founder.
“Initial results show promising neuron spike detection,” Musk said in a post on the social media platform X on Monday.
Spikes are activity by neurons, which the National Institute of Health describes as cells that use electrical and chemical signals to send information around the brain and to the body.
The U.S. Food and Drug Administration had given the company clearance last year to conduct its first trial to test its implant on humans, a critical milestone in the startup’s ambitions to help patients overcome paralysis and a host of neurological conditions.
In September, Neuralink said it received approval for recruitment for the human trial.
The study uses a robot to surgically place a brain-computer interface (BCI) implant in a region of the brain that controls the intention to move, Neuralink said previously, adding that its initial goal is to enable people to control a computer cursor or keyboard using their thoughts alone.
The implants’ “ultra-fine” threads help transmit signals in participants’ brains, Neuralink has said.
The first product from Neuralink would be called Telepathy, Musk said in a separate post on X.
The startup’s PRIME Study is a trial for its wireless brain-computer interface to evaluate the safety of the implant and surgical robot.
Neuralink did not immediately respond to a Reuters request for further details.
The company has faced calls for scrutiny regarding its safety protocols. Reuters reported earlier this month that the company was fined for violating U.S. Department of Transportation (DOT) rules regarding the movement of hazardous materials.
The company was valued at about $5 billion last June, but four lawmakers in late November asked the U.S. Securities and Exchange Commission to investigate whether Musk had misled investors about the safety of its technology after veterinary records showed problems with the implants on monkeys included paralysis, seizures, and brain swelling.
Musk wrote in a social media post on Sept. 10 that “no monkey has died as a result of a Neuralink implant.” He added that the company chose “terminal” monkeys to minimize risk to healthy ones.
Reporting by Akash Sriram and Kanjyik Ghosh in Bengaluru; Editing by Sherry Jacob-Phillips and Jacqueline Wong
OAN’s John Hines6:25 PM - Monday, January 29, 2024 Georgia Congresswoman Marjorie Taylor Greene says her committee will act to impeach D.H.S.…
Chicago continues to buckle under the strain of the migrant crisis as Mayor Brandon Johnson’s administration prepares to issue eviction notices to hundreds of migrants in city shelters.
The Biden Administration reacts to the deaths of three U.S. service members near Syria and the IRS contractor who leaked Trump’s tax returns is sentenced.
Americans could soon be forced to submit to mandatory vaccines and 24/7 surveillance under a new “pandemic treaty” proposed by Joe Biden and leaders at the W.H.O..
The first human patient has received an implant from brain-chip startup Neuralink and is recovering well.
A near-term global slowdown is causing pain, including bankruptcies, scrapped initial public offerings, and production cuts.
January 29, 2024 – 6:18 AM PST (Reuters) – Microsoft (MSFT.O) is expected to report a 15.8% jump in quarterly revenue, its best growth…
X is in the process of hiring 100 content moderators for a new office in Austin, Texas that will focus on fighting child abuse content.
What is the significance of Neuralink’s successful implantation of a brain-chip in its first human patient?
Neuralink, the brain-chip startup founded by Elon Musk, has successfully implanted its first human patient with a brain-chip. According to Musk, the patient is recovering well after the implantation procedure, which marks a major milestone for the company.
Musk announced the successful implantation on Monday, stating that the initial results show promising neuron spike detection. Neuron spikes are activities generated by neurons, which are cells that use electrical and chemical signals to transmit information within the brain and throughout the body, as described by the National Institute of Health.
Last year, the U.S. Food and Drug Administration granted Neuralink clearance to conduct its first trial on humans, a significant achievement for the company’s ambitions to assist patients in overcoming paralysis and other neurological conditions. In September, Neuralink received approval for recruitment of participants in the human trial.
The trial involves the use of a robot to surgically place a brain-computer interface (BCI) implant in a specific region of the brain responsible for controlling movement intentions. Neuralink’s initial objective is to enable individuals to control a computer cursor or keyboard using their thoughts alone. The implants, made up of ”ultra-fine” threads, aid in transmitting signals within the participants’ brains.
Musk mentioned that the first product to be developed by Neuralink will be called Telepathy, emphasizing the company’s focus on enabling communication through brain-computer interfaces.
The PRIME Study, conducted by Neuralink, aims to evaluate the safety of the wireless brain-computer interface and the surgical robot used in the implantation procedure. However, the company has not provided further details in response to a request by Reuters.
Neuralink has faced scrutiny regarding its safety protocols. Earlier this month, Reuters reported that the company was fined for violating U.S. Department of Transportation rules related to the transportation of hazardous materials. Furthermore, in late November, four lawmakers urged the U.S. Securities and Exchange Commission to investigate whether Musk misled investors about the safety of Neuralink’s technology, as veterinary records showed complications in monkeys implanted with the device, including paralysis, seizures, and brain swelling.
Musk defended the safety of the Neuralink implant, stating that no monkeys had died as a result of the procedure. He clarified that the company had chosen terminal monkeys to minimize risks to healthy ones.
The successful implantation of the brain-chip in the first human patient is a significant breakthrough for Neuralink and highlights the company’s dedication to advancing brain-computer interfaces. As the technology continues to develop, it holds the potential to revolutionize the lives of individuals suffering from neurological conditions or paralysis.
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
